Max Kepler signs with Diamondbacks while still serving suspension for performance-enhancing drugs

The Arizona Diamondbacks have signed outfielder Max Kepler, who is still serving an 80-game suspension for testing positive for performance-enhancing drugs. Kepler will not be able to report to the team until June 25, when his suspension ends. Kepler tested positive in January for Epitrenbolone, a metabolite of Trenbolone that's contained in some products used in body-building stores and has been used in products to promote cattle growth.